11 June 2018

Early-Stage Clinical Trials: The CHUS Joins the CATALIS Initiative 

Centre de recherche du CHUSThe Centre hospitalier universitaire de Sherbrooke (CHUS) – through its research centre – is one of two new health institutions to become partners in the CATALIS initiative, with the Centre hospitalier universitaire (CHU) de Québec – Université Laval being the other.

Already grouping together the Centre hospitalier universitaire de Montréal (CHUM), the Centre hospitalier universitaire Sainte-Justine, and the McGill University Health Centre (MUHC) as well as nearly a dozen funding partners, CATALIS aims to position Québec as a global force in terms of early-stage clinical trials – the first phase in drug research.

Within the next 5 years, the CR-CHUS hopes to double its early-stage clinical trials, particularly in radiochemistry and medical imaging. It will have access to $300 000 granted by the Government of Québec, as announced at the BIO International Conference in Boston.

» For more details : CATALIS and La Tribune

Back to the news

Leave a Reply

Your email address will not be published. Required fields are marked *

Sherbrooke Innopole’s mandate ends on March 31, 2024. We invite you to contact Entreprendre Sherbrooke or the Service du développement économique of the Ville de Sherbrooke for further services.
Thank you to all Sherbrooke industrial and technological businesses, as well as to all our partners for the trust granted since 2009!